Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for CVRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.112M
March 31, 2026 -0.122M
December 31, 2025 -0.068M
September 30, 2025 -0.295M
June 30, 2025 -0.103M
March 31, 2025 -0.114M
December 31, 2024 -0.052M
September 30, 2024 -0.037M
June 30, 2024 -0.355M
March 31, 2024 -0.917M
December 31, 2023 -0.169M
September 30, 2023 -0.039M
June 30, 2023 -0.143M
Date Value
March 31, 2023 -0.24M
December 31, 2022 -0.079M
September 30, 2022 -0.264M
June 30, 2022 -0.049M
March 31, 2022 -0.293M
December 31, 2021 -0.538M
September 30, 2021 -0.165M
June 30, 2021 -0.379M
March 31, 2021 -0.101M
December 31, 2020 -0.101M
September 30, 2020 -0.118M
June 30, 2020 -0.043M
March 31, 2020 -0.049M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
NeuroPace, Inc. -0.125M
Accuray, Inc. -1.353M
Micron Solutions, Inc. --
Orthofix Medical, Inc. -12.57M
ResMed, Inc. -383.65M